Doctor of Osteopathy Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

Vern Strubeck

Adult Medicine Tucson, AZ Doctor of Osteopathy

NPI 1013214774 CMS profile 506059

3945 E Paradise Falls Drive, 201, Tucson, AZ 85712

Open in the dashboard

General payments

$1,428

108 records reported · program years 2019–2020

Research payments

$0

Paid to them · None reported · program years 2019–2020

Ownership & investment interest

$0

None reported

Through program year 2020, Vern Strubeck of Tucson, AZ is reported in the CMS Open Payments database as having received $1,428 across 108 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Adult Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $14 1
2019 General $1,414 107

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vern Strubeck
  • Adult Medicine median
  • Middle half of Adult Medicine
  • National median

In program year 2025, general payments to Vern Strubeck were reported at $0. Among 691 Adult Medicine profiles paid that year, the median was $151 and the middle half received between $51 and $528.

Show as a table
Year Vern Strubeck Adult Medicine median Middle half National median
2019 $1,414 $140 $41–$517 $163
2020 $14 $107 $25–$378 $114
2021 $0 $136 $32–$529 $132
2022 $0 $138 $39–$492 $149
2023 $0 $155 $46–$483 $160
2024 $0 $153 $46–$554 $164
2025 $0 $151 $51–$528 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. Lilly USA, LLC $251 17 payments
  2. AstraZeneca Pharmaceuticals LP $239 10 payments
  3. Novo Nordisk Inc $189 16 payments
  4. Merck Sharp & Dohme Corporation $141 14 payments
  5. Janssen Pharmaceuticals, Inc $135 15 payments
  6. GlaxoSmithKline, LLC. $134 12 payments
  7. Amgen Inc. $98 5 payments
  8. Sanofi-Aventis U.S. LLC $72 5 payments
  9. Pfizer Inc. $45 4 payments
  10. Salix Pharmaceuticals, a division of Bausch Health US, LLC $41 3 payments
  11. Other $82 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Food and Beverage $1,422 107 payments
  2. Education $6 1 payment
Products named General payments · program years 2019–2020
  1. JARDIANCE $199 13 payments
  2. SYMBICORT $193 5 payments
  3. FARXIGA $186 5 payments
  4. XARELTO $135 15 payments
  5. INVOKANA $135 15 payments
  6. STEGLATRO $117 11 payments
  7. JANUVIA $117 11 payments
  8. Ozempic $115 10 payments
  9. ANORO $112 10 payments
  10. TRULICITY $103 10 payments
  11. Other $1,165 97 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

108 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Medicine in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record